Analyst Profile

Followed by 2,083 followers
.
Salveen Richter

Salveen Richter

Goldman Sachs
Wall Street Analyst
#146 out of 8,141 Wall Street Analysts
#259 out of 24,284 experts

Success Rate

56%
116 out of 209 transactions made a profit

Average Return

+26.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Salveen Richter's trades since 2010 and holding each position for 1 Year would result in 55.50% of your transactions generating a profit, with an average return of 26.9% per rating.

Stock Rating Distribution

352Ratings
60.80% Buy
31.82% Hold
7.39% Sell
Distribution of Salveen Richter's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Intellia Therapeutics Inc
(NTLA)
Rating:Buy
Date:Sep 18, 2020 - Sep 18, 2021
Return:+569.00%
The most profitable rating made by Salveen Richter

Salveen Richter's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
GENZ
Genzyme
Aug 30, 2010
Hold
Reiterated
1Ratings
0.00%
Anthera Pharmaceuticals
Dec 02, 2011
Buy
Initiated
$13.00
(12999900.00% Upside)
1Ratings
0%
-90.10%
RDEA
Ardea Biosciences
May 08, 2012
Hold
Downgraded
1Ratings
0.00%
AVEO Pharma
May 03, 2013
Hold
Downgraded
$2.00
(-86.55% Downside)
3Ratings
0%
-76.05%
ONXX
Onyx Pharma
Aug 09, 2013
Buy
Reiterated
2Ratings
0%
-3.25%
Fortress Biotech
Oct 15, 2013
Hold
Downgraded
$2.00
(175.86% Upside)
2Ratings
0%
-82.10%
United Therapeutics
Oct 29, 2013
Hold
Assigned
$76.00
(-71.65% Downside)
3Ratings
0.00%
DNDNQ
Dendreon Corp
Nov 11, 2013
Hold
Assigned
4Ratings
0.00%
AEGR
Aegerion
Nov 19, 2013
Buy
Reiterated
7Ratings
57%
+86.19%
NPSP
NPS Pharma
Jan 06, 2014
Buy
Assigned
5Ratings
100%
+81.15%
List of latest recommendations made by Salveen Richter. Click to expand and see Salveen Richter's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >